Accuray (ARAY) EPS (Weighted Average and Diluted) (QoQ) (2010 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Accuray | 47,295.88 | -38.49 Mn | 25.29 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 38.89% |
| Sep 30, 2025 | -431.51% |
| Jun 30, 2025 | 642.97% |
| Mar 31, 2025 | -150.00% |
| Dec 31, 2024 | 150.00% |
| Sep 30, 2024 | -181.05% |
| Jun 30, 2024 | 182.25% |
| Mar 31, 2024 | 40.00% |
| Dec 31, 2023 | -233.33% |
| Sep 30, 2023 | -148.97% |
| Jun 30, 2023 | 512.64% |
| Mar 31, 2023 | 150.00% |
| Dec 31, 2022 | 66.67% |
| Sep 30, 2022 | -220.23% |
| Jun 30, 2022 | 599.05% |
| Sep 30, 2021 | 91.67% |
| Jun 30, 2021 | -2,765.32% |
| Mar 31, 2021 | -108.38% |
| Dec 31, 2020 | 1,040.31% |
| Sep 30, 2020 | -80.25% |
| Jun 30, 2020 | -25.99% |
| Mar 31, 2020 | -75.00% |
| Dec 31, 2019 | 209.09% |
| Sep 30, 2019 | -450.00% |
| Jun 30, 2019 | -100.00% |
| Mar 31, 2019 | 80.00% |
| Jun 30, 2012 | -33.33% |
| Mar 31, 2012 | -40.00% |
| Dec 31, 2011 | 60.53% |
| Sep 30, 2011 | 5.00% |
| Jun 30, 2011 | -1,900.00% |
| Mar 31, 2011 | -128.57% |
| Dec 31, 2010 | 187.50% |